Graphical AbstractA broad host-range CRISPR-Cas9 delivery tool was developed and used to conjugatively remove antimicrobial resistance (AMR) plasmids (top) and protect a series of coliform andPseudomonasisolates from AMR plasmid uptake (bottom).